Best practices for the interpretation and reporting of clinical whole genome sequencing

CA Austin-Tse, V Jobanputra, DL Perry, D Bick… - NPJ genomic …, 2022 - nature.com
Whole genome sequencing (WGS) shows promise as a first-tier diagnostic test for patients
with rare genetic disorders. However, standards addressing the definition and deployment …

Genomic frontiers in congenital heart disease

SU Morton, D Quiat, JG Seidman… - Nature Reviews …, 2022 - nature.com
The application of next-generation sequencing to study congenital heart disease (CHD) is
increasingly providing new insights into the causes and mechanisms of this prevalent birth …

The next-generation Open Targets Platform: reimagined, redesigned, rebuilt

D Ochoa, A Hercules, M Carmona… - Nucleic acids …, 2023 - academic.oup.com
Abstract The Open Targets Platform (https://platform. opentargets. org/) is an open source
resource to systematically assist drug target identification and prioritisation using publicly …

An evidence‐based framework for evaluating pharmacogenomics knowledge for personalized medicine

M Whirl‐Carrillo, R Huddart, L Gong… - Clinical …, 2021 - Wiley Online Library
Clinical annotations are one of the most popular resources available on the
Pharmacogenomics Knowledgebase (PharmGKB). Each clinical annotation summarizes the …

Rates and classification of variants of uncertain significance in hereditary disease genetic testing

E Chen, FM Facio, KW Aradhya, S Rojahn… - JAMA network …, 2023 - jamanetwork.com
Importance Variants of uncertain significance (VUSs) are rampant in clinical genetic testing,
frustrating clinicians, patients, and laboratories because the uncertainty hinders diagnoses …

The DisGeNET knowledge platform for disease genomics: 2019 update

J Piñero, JM Ramírez-Anguita… - Nucleic acids …, 2020 - academic.oup.com
One of the most pressing challenges in genomic medicine is to understand the role played
by genetic variation in health and disease. Thanks to the exploration of genomic variants at …

Evidence-based assessment of genes in dilated cardiomyopathy

E Jordan, L Peterson, T Ai, B Asatryan, L Bronicki… - Circulation, 2021 - ahajournals.org
Background: Each of the cardiomyopathies, classically categorized as hypertrophic
cardiomyopathy, dilated cardiomyopathy (DCM), and arrhythmogenic right ventricular …

GA4GH: International policies and standards for data sharing across genomic research and healthcare

HL Rehm, AJH Page, L Smith, JB Adams, G Alterovitz… - Cell genomics, 2021 - cell.com
Summary The Global Alliance for Genomics and Health (GA4GH) aims to accelerate
biomedical advances by enabling the responsible sharing of clinical and genomic data …

Recommendations for clinical interpretation of variants found in non-coding regions of the genome

JM Ellingford, JW Ahn, RD Bagnall, D Baralle… - Genome medicine, 2022 - Springer
Background The majority of clinical genetic testing focuses almost exclusively on regions of
the genome that directly encode proteins. The important role of variants in non-coding …

Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association

K Musunuru, RE Hershberger, SM Day… - Circulation: Genomic …, 2020 - ahajournals.org
Advances in human genetics are improving the understanding of a variety of inherited
cardiovascular diseases, including cardiomyopathies, arrhythmic disorders, vascular …